Joshua R Lamstein - Net Worth and Insider Trading

Joshua R Lamstein Net Worth

The estimated net worth of Joshua R Lamstein is at least $5,936 dollars as of 2024-11-08. Joshua R Lamstein is the Director of PAVmed Inc and owns about 5,581 shares of PAVmed Inc (PAVM) stock worth over $5,888. Joshua R Lamstein is also the Chairman, 10% Owner of Scopus BioPharma Inc and owns about 119,997 shares of Scopus BioPharma Inc (SCPS) stock worth over $48. Details can be seen in Joshua R Lamstein's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joshua R Lamstein has not made any transactions after 2021-08-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Joshua R Lamstein

To

Joshua R Lamstein Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joshua R Lamstein owns 2 companies in total, including PAVmed Inc (PAVM) , and Scopus BioPharma Inc (SCPS) .

Click here to see the complete history of Joshua R Lamstein’s form 4 insider trades.

Insider Ownership Summary of Joshua R Lamstein

Ticker Comapny Transaction Date Type of Owner
PAVM PAVmed Inc 2016-11-18 director
SCPS Scopus BioPharma Inc 2021-08-27 director & Chairman

Joshua R Lamstein Latest Holdings Summary

Joshua R Lamstein currently owns a total of 2 stocks. Among these stocks, Joshua R Lamstein owns 5,581 shares of PAVmed Inc (PAVM) as of November 18, 2016, with a value of $5,888 and a weighting of 99.19%. Joshua R Lamstein also owns 119,997 shares of Scopus BioPharma Inc (SCPS) as of August 27, 2021, with a value of $48 and a weighting of 0.81%.

Latest Holdings of Joshua R Lamstein

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PAVM PAVmed Inc 2016-11-18 5,581 1.06 5,888
SCPS Scopus BioPharma Inc 2021-08-27 119,997 0.00 48

Holding Weightings of Joshua R Lamstein


Joshua R Lamstein Form 4 Trading Tracker

According to the SEC Form 4 filings, Joshua R Lamstein has made a total of 0 transactions in PAVmed Inc (PAVM) over the past 5 years. The most-recent trade in PAVmed Inc is the acquisition of 13 shares on November 18, 2016, which cost Joshua R Lamstein around $2,190.

According to the SEC Form 4 filings, Joshua R Lamstein has made a total of 6 transactions in Scopus BioPharma Inc (SCPS) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Scopus BioPharma Inc is the acquisition of 400 shares on August 27, 2021, which cost Joshua R Lamstein around $1,980.

Insider Trading History of Joshua R Lamstein

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joshua R Lamstein Trading Performance

GuruFocus tracks the stock performance after each of Joshua R Lamstein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joshua R Lamstein is -35.01%. GuruFocus also compares Joshua R Lamstein's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joshua R Lamstein within 3 months outperforms 0 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Joshua R Lamstein's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Joshua R Lamstein

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 7 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.03 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -2 LIMIT LIMIT LIMIT LIMIT LIMIT

Joshua R Lamstein Ownership Network

Ownership Network List of Joshua R Lamstein

No Data

Ownership Network Relation of Joshua R Lamstein

Insider Network Chart

Joshua R Lamstein Owned Company Details

What does PAVmed Inc do?

Who are the key executives at PAVmed Inc?

Joshua R Lamstein is the director of PAVmed Inc. Other key executives at PAVmed Inc include General Counsel Michael Adam Gordon , Chief Operating Officer Shaun O'neil , and director & 10 percent owner & Chairman and CEO Lishan Aklog .

PAVmed Inc (PAVM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PAVmed Inc (PAVM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PAVmed Inc (PAVM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PAVmed Inc (PAVM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

PAVmed Inc Insider Transactions

No Available Data

Joshua R Lamstein Mailing Address

Above is the net worth, insider trading, and ownership report for Joshua R Lamstein. You might contact Joshua R Lamstein via mailing address: 420 Lexington Avenue, Suite 300, New York Ny 10170.